RFI Partners with Ilhwa on Ginseng Technology

February 20, 2013

1 Min Read
Supply Side Supplement Journal logo in a gray background | Supply Side Supplement Journal

BLAUVELT, N.Y.RFI, a company focusing on formulations, products and solutions for the dietary supplement industry, has partnered with Ilhwa North America Inc., a nutraceutical company specializing in pharmaceuticals, ginseng and beverages. RFI and Ilhwa will be collaborating and researching  for new discoveries in ginseng technology.

GS15-4®, a ginseng extract manufactured by Ilhwa, uses a patented high-yield, enzyme fermentation to produce a balanced extract in an end-stage metabolite form.

According to Ilhwa, the extract is clinically proven to provide 15 times higher absorption, four times faster absorption and four times more consistency.

RFI recently released its new FermaPro® line of fermented ingredients, including cereal grasses, vegetables, fruits, spices and seeds in January.

Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.

You May Also Like